$2.89 -0.04 (-1.37%)
2/13/2012 10:17 AM

AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Featured Broker Partners


Advertisement